AR227201A1 - Procedimiento para preparar polvo capaz de ser reconstituido mediante el agregado de agua para dar una suspension farmaceuticamente microcapsulas de sal de adicion de acido de bacampicilina en un medio de suspension acuosa - Google Patents

Procedimiento para preparar polvo capaz de ser reconstituido mediante el agregado de agua para dar una suspension farmaceuticamente microcapsulas de sal de adicion de acido de bacampicilina en un medio de suspension acuosa

Info

Publication number
AR227201A1
AR227201A1 AR286473A AR28647381A AR227201A1 AR 227201 A1 AR227201 A1 AR 227201A1 AR 286473 A AR286473 A AR 286473A AR 28647381 A AR28647381 A AR 28647381A AR 227201 A1 AR227201 A1 AR 227201A1
Authority
AR
Argentina
Prior art keywords
water
suspension
reconstituted
pharmaceutically
give
Prior art date
Application number
AR286473A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR227201A1 publication Critical patent/AR227201A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AR286473A 1980-08-22 1981-08-19 Procedimiento para preparar polvo capaz de ser reconstituido mediante el agregado de agua para dar una suspension farmaceuticamente microcapsulas de sal de adicion de acido de bacampicilina en un medio de suspension acuosa AR227201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/180,537 US4321253A (en) 1980-08-22 1980-08-22 Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration

Publications (1)

Publication Number Publication Date
AR227201A1 true AR227201A1 (es) 1982-09-30

Family

ID=22660812

Family Applications (1)

Application Number Title Priority Date Filing Date
AR286473A AR227201A1 (es) 1980-08-22 1981-08-19 Procedimiento para preparar polvo capaz de ser reconstituido mediante el agregado de agua para dar una suspension farmaceuticamente microcapsulas de sal de adicion de acido de bacampicilina en un medio de suspension acuosa

Country Status (41)

Country Link
US (1) US4321253A (xx)
JP (1) JPS5775986A (xx)
KR (1) KR860000513B1 (xx)
AR (1) AR227201A1 (xx)
AT (1) AT370994B (xx)
AU (1) AU529965B2 (xx)
BE (1) BE890028A (xx)
BG (1) BG42000A3 (xx)
CA (1) CA1137414A (xx)
CH (1) CH650674A5 (xx)
CS (1) CS225845B2 (xx)
DD (1) DD201644A5 (xx)
DE (1) DE3132614C2 (xx)
DK (1) DK158971C (xx)
DZ (1) DZ315A1 (xx)
ES (1) ES504905A0 (xx)
FI (1) FI72647C (xx)
FR (1) FR2488798A1 (xx)
GB (1) GB2082539B (xx)
GR (1) GR74983B (xx)
HK (1) HK43786A (xx)
HU (1) HU188679B (xx)
IE (1) IE51506B1 (xx)
IL (1) IL63617A (xx)
IN (1) IN156538B (xx)
IT (1) IT1138161B (xx)
KE (1) KE3626A (xx)
LU (1) LU83572A1 (xx)
MX (1) MX5731A (xx)
MY (1) MY8600597A (xx)
NL (1) NL191978C (xx)
NO (1) NO154821C (xx)
NZ (1) NZ198106A (xx)
PH (1) PH17125A (xx)
PL (1) PL232141A1 (xx)
PT (1) PT73555B (xx)
RO (1) RO82679B (xx)
SE (1) SE448819B (xx)
SU (1) SU1364226A3 (xx)
YU (1) YU43985B (xx)
ZA (1) ZA815793B (xx)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
WO1984000004A1 (en) * 1982-06-14 1984-01-05 Key Pharma Sustained release aspirin
WO1984000295A1 (en) * 1982-07-09 1984-02-02 Key Pharma Sustained release quinidine dosage form
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ES2099438T3 (es) * 1992-04-30 1997-05-16 Schering Corp Polvo seco y estable de cefalosporina hidratada para formulacion de suspension oral.
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
IN191482B (xx) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
JP4711478B2 (ja) * 1999-08-13 2011-06-29 旭化成ケミカルズ株式会社 味がマスクされた薬物
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
DK1276470T3 (da) 2000-04-20 2007-06-18 Novartis Ag Smagskaskerende overtrækssammensætning
EP1292285A4 (en) * 2000-06-02 2009-07-22 Eisai Corp North America SYSTEMS FOR DISPENSING BIOACTIVE AGENTS
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
WO2002096392A1 (en) * 2001-05-31 2002-12-05 Cima Labs Inc. Taste-masking of highly water-soluble drugs
KR20030015655A (ko) * 2001-08-17 2003-02-25 한미약품공업 주식회사 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
WO2003084517A2 (fr) * 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules d’amoxicilline
PT1492511E (pt) 2002-04-09 2009-04-09 Flamel Tech Sa Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
JP6184656B1 (ja) * 2015-10-13 2017-08-23 テクノガード株式会社 胃腸管粘膜保護組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
ZA718014B (en) 1970-12-23 1972-08-30 Beecham Group Ltd Pharmaceutical formulations
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
GB1479655A (en) 1974-03-08 1977-07-13 Beecham Group Ltd Antibiotic preparations
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
ZA793934B (en) * 1978-08-04 1980-07-30 Beecham Group Ltd Powders
JPS57105316A (en) * 1980-12-23 1982-06-30 Hitachi Cable Ltd Method of fitting heat-shrinkable tube

Also Published As

Publication number Publication date
IL63617A0 (en) 1981-11-30
BE890028A (fr) 1982-02-22
DE3132614C2 (de) 1985-08-22
NL191978B (nl) 1996-08-01
CS225845B2 (en) 1984-02-13
NL8103902A (nl) 1982-03-16
DD201644A5 (de) 1983-08-03
FR2488798A1 (fr) 1982-02-26
NL191978C (nl) 1996-12-03
BG42000A3 (en) 1987-09-15
CH650674A5 (fr) 1985-08-15
FI72647B (fi) 1987-03-31
HU188679B (en) 1986-05-28
JPH0248525B2 (xx) 1990-10-25
DK158971C (da) 1991-01-07
RO82679A (ro) 1984-05-23
IT1138161B (it) 1986-09-17
KR830005850A (ko) 1983-09-14
CA1137414A (en) 1982-12-14
LU83572A1 (fr) 1982-04-14
IE811911L (en) 1982-02-22
FI72647C (fi) 1987-07-10
ZA815793B (en) 1982-08-25
RO82679B (ro) 1984-07-30
SU1364226A3 (ru) 1987-12-30
IL63617A (en) 1984-11-30
AU7441681A (en) 1982-04-01
ATA362781A (de) 1982-10-15
US4321253A (en) 1982-03-23
IT8123587A0 (it) 1981-08-20
PH17125A (en) 1984-06-01
DZ315A1 (fr) 2004-09-13
JPS5775986A (en) 1982-05-12
PT73555B (en) 1983-07-14
AT370994B (de) 1983-05-25
DK158971B (da) 1990-08-13
HK43786A (en) 1986-06-20
DK372181A (da) 1982-02-23
NO154821B (no) 1986-09-22
SE448819B (sv) 1987-03-23
MX5731A (es) 1993-11-01
KE3626A (en) 1986-05-16
GB2082539B (en) 1984-01-18
DE3132614A1 (de) 1982-05-19
IN156538B (xx) 1985-08-31
SE8104974L (sv) 1982-02-23
ES8303091A1 (es) 1983-02-01
AU529965B2 (en) 1983-06-30
FR2488798B1 (xx) 1985-01-11
YU43985B (en) 1990-02-28
ES504905A0 (es) 1983-02-01
KR860000513B1 (ko) 1986-05-02
GB2082539A (en) 1982-03-10
GR74983B (xx) 1984-07-12
NO812827L (no) 1982-02-23
YU201781A (en) 1984-04-30
IE51506B1 (en) 1987-01-07
NZ198106A (en) 1983-12-16
PT73555A (en) 1981-09-01
NO154821C (no) 1987-01-07
FI812574L (fi) 1982-02-23
PL232141A1 (xx) 1982-03-15
MY8600597A (en) 1986-12-31

Similar Documents

Publication Publication Date Title
AR227201A1 (es) Procedimiento para preparar polvo capaz de ser reconstituido mediante el agregado de agua para dar una suspension farmaceuticamente microcapsulas de sal de adicion de acido de bacampicilina en un medio de suspension acuosa
IT1129759B (it) Metodo per ricuperare in forma attiva i componenti del sistema catalitico della sintesi dell'acido tereftalico
ES553714A0 (es) Procedimiento para la preparacion de una composicion que contiene una sal de acido hialuronico.
FR2554001B1 (fr) Capsule osmotique pour l'apport de substances actives a un milieu environnant
PH17656A (en) Stable monaqueous solution of tetracycline salt
IT1178223B (it) Sistema per modificare l'assetto di un veicolo dalla conduzione con due ruote motrici a quattro ruote motrici
IL73594A (en) Carriers for the preparation of controlled long-acting pharmaceuticals for oral administration
ES521728A0 (es) Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.
CS415791A3 (en) Crystallizing acid addition salts of cephem
DE3163511D1 (en) Preparation of the calcium salt of alpha-hydroxy-gamma-methylmercaptobutyric acid
ZA909949B (en) Injectable formulations containing the sodium salt of naproxen
HK61289A (en) Use of salicylic acid derivatives as anti-smut agents
IT1142096B (it) Derivati dell'acido 7-acilammino cefalosporanico e procedimenti per la loro preparazione
IT1126544B (it) Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico
IT8119831A0 (it) Procedimento per la preparazione dell'acido 7-(d(-)-alfa-ammino-p.idrossifenilacetammido)desacetossicefalosporanico.
GB2104509B (en) New synthetic route to optically active 2-penem-3-carboxylic acid derivatives
FR2545678B1 (fr) Cultivateur equipe de roues de terre accroissant sa stabilite
ITTO930761A1 (it) Fiala a soluzione per infusione di acido tiottico in forma di sale idrosolubile dell'acido tiottico.
IT1199103B (it) Procedimento per la preparazione dell'acido 1-naftol-4-solfonico
IT1155201B (it) Procedimento per la preparazione di un derivato dell'acido cefalosporanico
IT1141075B (it) Procedimento per la preparazione di derivati dell'acido 7-amminocefalosporanico
ES537074A0 (es) Un procedimiento para la preparacion de una sal de s-adenosil-l-metionina
TH393EX (th) ตลับแผ่นกลมแม่เหล็กบันทึกภาพนิ่ง
PL276865A1 (en) Preparation method for sodium salt of the 7/z-2-(aminetiazolile-4)2-metoxyiminoacetylamine/-cephalospornic acid
IT8548980A0 (it) Procedimento per la preparazione di sali dell'acido ialuronico